CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 4,500 shares at an average $1.83 ($8,229)
- 4 Open-market buy President and CEO bought 2,750 shares at $1.92 ($5,280)
- 4 Open-market buy President and CEO bought 4,500 shares at $1.46 ($6,570)
- 4 Shares withheld for taxes President and CEO gave up 31,446 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Vice President, Devices gave up 12,358 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,632 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 15,000 shares at an average $1.24 ($18,586)
- 4 Open-market buy President and CEO bought 5,000 shares at an average $1.60 ($8,004)
- 4 Open-market buy President and CEO bought 13,500 shares at $1.39 ($18,700)
- 4 Grant or award Chief Financial Officer acquired 50,345 shares (grant or award)
- 4 Grant or award Senior Vice President, Devices acquired 30,155 shares (grant or award)
- 4 Open-market buy President and CEO bought 5,000 shares at $2.20 ($11,000)
- 4 Open-market buy President and CEO bought 3,500 shares at $2.94 ($10,290)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 23 · 442 filings